top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profusa, Inc. - Common Stock (NQ:PFSA)

0.1090 -0.0055 (-4.80%)
Streaming Delayed Price Updated: 12:04 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Profusa, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces Listing Transfer to The Nasdaq Capital Market
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Receives Favorable Nasdaq Listing Determination
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces 1-for-75 Reverse Stock Split
From Profusa, Inc.
Via GlobeNewswire
News headline image
$6 Billion Peripheral Artery Disease (PAD) Market: Innovation at a Premium (PFSA, BSX, ABT)
Via AB Newswire
News headline image
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
From Profusa, Inc.
Via GlobeNewswire
News headline image
Nika Pharmaceuticals (OTCQB: NIKA) Targets Immune Health Breakthroughs Across HIV, Cancer, and Chronic Diseases
Via AB Newswire
Topics Intellectual Property
News headline image
Peraso Inc. (NASDAQ: PRSO) Taps $15B U.S. Market as Robotaxi Fleets Hit the Fast Lane
Via AB Newswire
News headline image
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35
From Profusa, Inc.
Via GlobeNewswire
News headline image
Santa’s Rally: CMCT, SURG, SIDU, MYSE, AZI – Stocks Under $5 to Watch Now – More Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces Third Quarter Business and Financial Highlights
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches
From Profusa, Inc.
Via GlobeNewswire
News headline image
Signal Advance (OTC: SIGL) Unveils Breakthrough AI-Resistant Encryption with Analog Guard®, Backed by IBM (NYSE: IBM) – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
From Profusa, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page